Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Progress in HER2-Positive Gastroesophageal Adenocarcinoma

(MedPage Today) -- After a period of relative inactivity, therapeutic development in HER2-positive gastroesophageal adenocarcinoma (GEA) has evolved rapidly over the past 5 years, establishing a new standard of care that was supplanted by another...

Progress in HER2-Positive Gastroesophageal Adenocarcinoma

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Tuesday 22 September →